Skip to content
healthcare.dev

Loratadine and Pseudoephedrine

NDC 51660-491, loratadine and pseudoephedrine, tablet, extended release, from Ohm Laboratories Inc..

Product NDC
51660-491
Status
Listed
Labeler
Ohm Laboratories Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51660-491 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
  • PSEUDOEPHEDRINE SULFATE240 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51660-491-695166004916910 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (51660-491-69)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 51660049169

    GET /v1/drugs/nadac/51660049169

Use it

Look up 51660-491 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51660-491 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51660-491. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.